| Literature DB >> 27433518 |
Rachael O Folarin1, Jamiu O Omirinde2, Ronald Bejide3, Tajudeen O Isola4, Levi I Usende4, Afisu Basiru4.
Abstract
This study investigates the comparative hepatoprotective activity of crude ethanol extracts of Cuscuta australis against acetaminophen (APAP) intoxication. Thirty-six rats were randomly divided into six groups of 6 replicates: Group 1 which served as control received water. Group 2 was orally administered 835 mg/kg body wt. of paracetamol on day 8. Groups 3 and 4 were orally administered ethanolic extracts of the seed of Cuscuta australis in doses of 125 mg/kg and 250 mg/kg, respectively, for 7 days and then intoxicated as in Group 2 on the 8th day. Groups 5 and 6 received similar oral doses of Cuscuta australis stem extracts for 7 days and then intoxicated as in Groups 3 and 4. Group 2 rats showed severe periportal hepatic necrosis, significantly elevated serum hepatic injury markers, markedly increased lipid peroxidation, and decreased hepatic antioxidant enzymes activities. Remarkably, Cuscuta australis (seed and stem) extract pretreatments in Groups 3, 4, 5, and 6, most especially, the stem extract pretreatment in Groups 5 and 6, improved better the hepatic histoarchitecture, the hepatocellular, and the oxidative stress injury markers in a dose-dependent manner. Conclusively, ethanol extractions of Cuscuta australis stem appear to protect the liver from acetaminophen intoxication better than the seed counterpart.Entities:
Year: 2014 PMID: 27433518 PMCID: PMC4897053 DOI: 10.1155/2014/730516
Source DB: PubMed Journal: Int Sch Res Notices ISSN: 2356-7872
Figure 1Photomicrographs of liver of acetaminophen-intoxicated rats and its amelioration by ethanolic extracts of Cuscuta australis seed and stem. Control: normal hepatic histoarchitecture (blue arrow); APAP/AP (acetaminophen): moderate portal congestion (asterisk) with severe periportal hepatic necrosis (red arrow), cellular infiltration (black arrow), and foci of hemorrhage in the hepatic parenchyma (white arrow); LCSD (low dose (125 mg) of Cuscuta australis seed) + AP: no visible lesion; HCSD (high dose (250 mg) of Cuscuta australis seed) + AP: periportal cellular infiltration (black arrow). LCST/HCST (low dose (125)/high dose (250 mg) of Cuscuta australis stem) + AP, respectively, showed normal hepatic histoarchitecture. Magnification: ×100; inset pictures at M ×400.
Effect of Cuscuta australis extracts on liver function markers in acetaminophen-intoxicated rats.
| Treatment | AST | ALT | TBIL |
|---|---|---|---|
| (A) CONTROL | 19.00 ± 2.86 | 10.80 ± 0.83 | 0.33 ± 0.04 |
| (B) APAP (865 mg) | 93.50 ± 11.66a | 50.67 ± 8.68a | 1.18 ± 0.14a |
| (C) LCSD + AP | 36.70 ± 3.03c | 19.00 ± 2.35c | 0.54 ± 0.01b |
| (D) HCSD + AP | 54.87 ± 5.19b | 26.33 ± 3.24b | 0.72 ± 0.07b |
| (E) LCST + AP | 45.83 ± 3.91b | 14.40 ± 1.20c | 0.62 ± 0.09b |
| (F) HCSD + AP | 23.00 ± 2.28d | 10.67 ± 0.99 | 0.43 ± 0.04c |
AST: aspartate aminotransferase; ALT: alanine aminotransferase; TBIL: Total Bilirubin; LCSD/HCSD: (Low dose (125 mg)/High dose (250 mg) of Cuscuta australis seed); LCST/HCST: (Low dose (125 mg)/High dose (250 mg) of Cuscuta australis stem). Values with different superscripts are significantly different; P-values: a P < 0.001: APAP compared with normal control; b P < 0.05, c P < 0.01, d P < 0.001: experimental groups compared with APAP.
Figure 2The effects of Cuscuta australis pretreatments on the antioxidant systems ((A) catalase (CAT), (B) superoxide dismutase (SOD), (C) glutathione peroxidase (GSH-PX), and (D) lipid peroxidation LPO) in hepatic tissues of acetaminophen-intoxicated rats. CT (control), APAP/AP (acetaminophen), LCSD/HCSD (low dose (125 mg)/high dose (250 mg) of Cuscuta australis seed), and LCST/HCST (low dose (125 mg)/high dose (250 mg) of Cuscuta australis stem). Values with different superscripts are significantly different; P values: a < 0.001: APAP compared with normal control; b < 0.05, c < 0.01, and d < 0.001: experimental groups compared with APAP.